Article révisé par les pairs
Fichier importé via le DOI

Documents en relation

DI-fusion

  • Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
    par Loi, Sherene , Salgado, Roberto , Adams, Sylvia , Pruneri, Giancarlo , Francis, Prudence P.A. , Lacroix-Triki, Magali , Joensuu, Heikki , Dieci, Maria Vittoria , Badve, Sunil , Demaria, Sandra , Gray, Robert , Munzone, Elisabetta , Drubay, Damien , Lemonnier, Jerome , Sotiriou, Christos , Kellokumpu-Lehtinen, Pirkko-Liisa , Vingiani, Andrea , Gray, Kathryn , Andre, Fabrice , Denkert, Carsten , Piccart-Gebhart, Martine , Roblin, Elvire , Michiels, Stefan
    Publication 2022-12
  • Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
    par Hudeček, Jan , Voorwerk, Leonie , van Seijen, Maartje , Nederlof, Iris , de Maaker, Michiel , van den Berg, Jose , van de Vijver, Koen K , Sikorska, Karolina , Adams, Sylvia , Demaria, Sandra , Viale, Giuseppe , Nielsen, Torsten O , Badve, Sunil , Michiels, Stefan , Symmans, William Fraser , Sotiriou, Christos , Rimm, David L , Hewitt, Stephen M , Denkert, Carsten , Loibl, Sibylle , Loi, Sherene , Bartlett, John M S , Pruneri, Giancarlo , Dillon, Deborah A , Cheang, Maggie C U , Tutt, Andrew M , Hall, Jacqueline Anne , Kos, Zuzana , Salgado, Roberto , Kok, Marleen , Horlings, Hugo Mark , International Immuno-Oncology Biomarker Working Group
    Publication 2020-01-01
  • Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
    par Rediti, Mattia , Venet, David , Joaquin Garcia, Andrea , Maetens, Marion M. , Vincent, Delphine , Majjaj, Samira , El-abed, Sarra , Di Cosimo, Serena , Ueno, Takayuki , Izquierdo, Miguel , Piccart-Gebhart, Martine , Pusztai, Lajos , Loi, Sherene , Salgado, Roberto , Viale, Giuseppe , Rothé, Françoise , Sotiriou, Christos
    Publication 2024-12-01
  • Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.
    par Langouo Fontsa, Mireille , Padonou, Francine , Willard-Gallo, Karen
    Publication 2024-08-01
  • The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.
    par Gonzalez-Ericsson, Paula I , Stovgaard, Elisabeth ES , Sua, Luz F , Reisenbichler, Emily , Kos, Zuzana , Carter, Jodi M , Michiels, Stefan , Le Quesne, John , Nielsen, Torsten O , Laenkholm, Anne-Vibeke , Fox, Stephen B , Adam, Julien , Bartlett, John Ms , Rimm, David L , Quinn, Cecily , Peeters, Dieter , Dieci, Maria V , Vincent-Salomon, Anne , Cree, Ian , Hida, Akira I , Balko, Justin M , Haynes, Harry HR , Frahm, Isabel , Acosta-Haab, Gabriela , Balancin, Marcelo , Bellolio, Enrique , Yang, Wentao , Kirtani, Pawan , Sugie, Tomoharu , Ehinger, Anna , Castaneda, Carlos Altamirano , Kok, Marleen , McArthur, Heather , Siziopikou, Kalliopi , Badve, Sunil , Fineberg, Susan , Gown, Allen A.M. , Viale, Giuseppe , Schnitt, Stuart J , Pruneri, Giancarlo , Penault-Llorca, Frederique , Hewitt, Stephen M , Thompson, E Aubrey , Allison, Kimberly H , Symmans, William Fraser , Bellizzi, Andrew M , Brogi, Edi , Moore, David A , Larsimont, Denis , Dillon, Deborah A , Lazar, Alexander , Lien, Huangchun , Goetz, Matthew P , Broeckx, Glenn , El Bairi, Khalid , Harbeck, Nadia , Cimino-Mathews, Ashley , Sotiriou, Christos , Adams, Sylvia , Liu, Shi-Wei , Loibl, Sibylle , Chen, I-Chun , Lakhani, Sunil R , Juco, Jonathan W , Denkert, Carsten , Blackley, Elizabeth EF , Demaria, Sandra , Leon-Ferre, Roberto , Gluz, Oleg , Zardavas, Dimitrios , Emancipator, Kenneth , Ely, Scott , Loi, Sherene , Salgado, Roberto , Sanders, Melinda M.E. , International Immuno-Oncology Biomarker Working Group
    Publication 2020-03-01